# Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study

> **NCT02847026** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 1144 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** IPV at 14 and 22 weeks of age, Rotarix
- **BIOLOGICAL:** IPV at 14 and 22 weeks of age, RotaTeq
- **BIOLOGICAL:** IPV at 14 and fIPV at 22 weeks, Rotarix
- **BIOLOGICAL:** IPV at 14 and fIPV at 22 weeks, RotaTeq
- **BIOLOGICAL:** IPV at 6 and fIPV at 22 weeks, Rotarix
- **BIOLOGICAL:** IPV at 6 and fIPV at 22 weeks, RotaTeq
- **BIOLOGICAL:** fIPV at 6-14-22 weeks of age, Rotarix
- **BIOLOGICAL:** fIPV at 6-14-22 weeks of age, RotaTeq

## Key facts

- **NCT ID:** NCT02847026
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 1144 (ACTUAL)
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847026, "Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02847026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*